Cassipa: New FDA Approved Medication for Opiate Maintenance Treatment
In September 2018, the U.S. Food and Drug Administration approved Cassipa which is buprenorphine and naloxone in a sublingual film to be used for opiate maintenance treatment. The action provides a new dose of 16 mg of buprenorphine and 4 mg of naloxone, which is...